|
| | WHO [3] | IDF [23] | AHA/NHLBI [21] | ATP III [5] | Japanese consensus [22] |
|
| | Impaired glucose regulation or hyperinsulinemia and more than two factors | WC and two or more risk factors |
at least 3 of |
Three or more of: | WC and two or more risk factors |
| Abdominal obesity | Waist: hip ratio ≥ 0.85 or BMI ≥30 kg/m2 | waist circumference at least
94 cm for Europoid men or 80 cm for Europoid women
90 cm for South Asian and South-East Asian men or 80 cm for South Asian and South-East Asian women
85 cm for Japanese men or 90 cm for Japanese women | WC (102 cm (40 inches) or higher in men
88 cm (35 inches) or higher in women) | Men: WC ≥ 102 cm
Women: WC ≥88 cm | Men: WC ≥ 85 cm
Women: WC ≥90 cm |
| Impaired glucose regulation | Fasting plasma ≥ 6.1 mmol/L or 2 h postglucose load ≥ 7.8 mmol/L | Fasting plasma ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 DM | Fasting plasma ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 DM | 110–126 mg/dL (6.1–7.0 mmol/L) | Fasting plasma ≥ 110 mg/dL |
| Hyperinsulinemia | Fasting serum insulin > 1/3rd quartile for control group | Not included | Not included | Not included | Not included |
| Triglycerides | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) | ≥150 mg/dL (1.7 mmol/L) or treatment for same |
| HDL concentration | Not included | Men: <40 mg/dL (1.03 mmol/L)
Women: <50 mg/dL (1.3 mmol/L) | Men: <40 mg/dL (1.03 mmol/L)
Women: <50 mg/dL (1.29 mmol/L) | Men: <40 mg/dL (1.03 mmol/L)
Women: <50 mg/dL (1.3 mmol/L) | <40 mg/dL (1.03 mmol/L) |
| Hypertension | ≥140/90 mmHg | ≥130/≥85 mmHg or treatment for same | elevated blood pressure 130/85 mmHg or higher or on medication | ≥130/≥80 mm Hg | ≥130/≥85 mm Hg or treatment for same |
|
Microalbuminuria | Albumin/creatinine
ratio > 30 mg/g | Not included | Not included | Not included | Not included |
|
